Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology
Open Access
- 12 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Nephrology
- Vol. 33 (6), 1343-1359
- https://doi.org/10.1007/s40620-020-00717-0
Abstract
Even though fertility is reduced, conception and delivery are possible in all stages of CKD. While successful planned pregnancies are increasing, an unwanted pregnancy may have long-lasting deleterious effects, hence the importance of birth control, an issue often disregarded in clinical practice. The evidence summarized in this position statement is mainly derived from the overall population, or other patient categories, in the lack of guidelines specifically addressed to CKD. Oestroprogestagents can be used in early, non-proteinuric CKD, excluding SLE and immunologic disorders, at high risk of thromboembolism and hypertension. Conversely, progestin only is generally safe and its main side effect is intramestrual spotting. Non-medicated intrauterine devices are a good alternative; their use needs to be carefully evaluated in patients at a high risk of pelvic infection, even though the degree of risk remains controversial. Barrier methods, relatively efficacious when correctly used, have few risks, and condoms are the only contraceptives that protect against sexually transmitted diseases. Surgical sterilization is rarely used also because of the risks surgery involves; it is not definitely contraindicated, and may be considered in selected cases. Emergency contraception with high-dose progestins or intrauterine devices is not contraindicated but should be avoided whenever possible, even if far preferable to abortion. Surgical abortion is invasive, but experience with medical abortion in CKD is still limited, especially in the late stages of the disease. In summary, personalized contraception is feasible, safe and should be offered to all CKD women of childbearing age who do not want to get pregnant.Keywords
This publication has 134 references indexed in Scilit:
- Weight change at 12 months in users of three progestin-only contraceptive methodsContraception, 2013
- Hypertension in WomenAdvances in Chronic Kidney Disease, 2013
- Women and Transplantation: Fertility, Sexuality, Pregnancy, ContraceptionAdvances in Chronic Kidney Disease, 2013
- Pregnancy in CKD: whom should we follow and why?Nephrology Dialysis Transplantation, 2012
- Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case–Control StudyPLoS Medicine, 2012
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysisEuropean Journal of Cancer, 2010
- Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 YearsCancer Epidemiology, Biomarkers & Prevention, 2009
- Chronic kidney disease in pregnancyBMJ, 2008
- A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2007
- The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rateBritish Journal of Clinical Pharmacology, 2006